Michelle Dawson posts

Post published on Twitter/X on 29 Dec 2022 17:05

Back to posts Previous post Next post
Twitter/X Clinical trial clinicaltrials.gov Extract quoted in the post Question asked by Dawson in the post External link integrated into the post Autism terms
Open original post

Information about the link integrated into the post

Clinical trial

Stanford University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2023). Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial. ClinicalTrials.gov. Stanford University.

More information

Structured cited links

1 cited resource

Clinical trial Fetched Post clinicaltrials.gov

Stanford University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2023). Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial. ClinicalTrials.gov. Stanford University.

Publication date
26 Apr 2023
Identifier
NCT05664789
Authors
Stanford University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Source
ClinicalTrials.gov
Reference type
clinical_trial
Publisher
Stanford University
Metadata source
clinicaltrials.gov

Abstract

The goal of this study is to target the neurobiology of restricted and repetitive behaviors in children with autism spectrum disorder using N-acetylcysteine (NAC), a well-tolerated nutritional supplement that has shown promise for reducing symptom severity in recent small-scale trials. The findings from this research will shed light on the mechanisms of action underlying the clinical benefits of NAC and the effects of NAC on altering restricted and repetitive behavior symptom severity in children with autism spectrum disorder. This is a 12-week double-blind, randomized, placebo-controlled trial of NAC.

Open source Link to cited source